Medilink News Summer 2021 - Page 9

Abingdon Health completes a delivery of 1m rapid antibody tests for COVID-19
Health to provide COVID-19 r international arrivals

OSTICS

Abingdon Health completes a delivery of 1m rapid antibody tests for COVID-19
Earlier this year , Abingdon Health , a York-based rapid test manufacturer and leading member of the UK-Rapid Test Consortium ( UK-RTC ), completed a delivery of 1m AbC-19 TM rapid antibody tests for COVID-19 .
In December , the company raised £ 22m on the AIM market of the London Stock Exchange . Since then , the business has continued to make progress on its rapid COVID-19 test , which had been the main contributor to an increase in its revenue so far .
Chris Yates , Chief Executive Officer at Abingdon Health , said : “ We have made significant commercial progress across the COVID-19 and non-COVID-19 markets and the company expects revenues to more than double this year . The company continues to develop a strong pipeline of opportunities for its AbC-19 TM rapid test . The lateral flow testing market is forecast to be worth $ 10.2bn by 2025 , and Abingdon remains well-positioned to be the ‘ go-to ’ provider for high quality rapid tests .”
Due to the growing global demand for lateral-flow tests , the company is continuing to scale up and is on track to be able to produce 150 million tests per annum by the end of 2021 .”
The company also signed a manufacturing agreement with BioSure . Under the agreement , Abingdon Health will manufacture BioSure ’ s own lateral flow tests for COVID-19 , helping speed up their roll-out in the UK and overseas .
Health to provide COVID-19 r international arrivals
illustrates the high standard and service levels that Yourgene . has been providing under our Genomics Services offering . We are extremely pleased to be at the forefront of this development as travel begins to open up .”
The company has also been successful with its tenders under the PHE ’ s National Microbiology Framework securing four lots with the total value of £ 22bn . The lots will allow Yourgene to offer its Clarigene ® SARS- CoV-2 PCR assay and associated Manchester-based clinical laboratory testing services under the National Microbiology Framework Agreement , as well as other testing or test development services .